ArticleslgStudy

chemistry

RD-162

RD-162 is a chemistry topic covered in the lgStudy science library. This page brings together a partial reference excerpt, illustrations, worked examples, real-world applications and a short study plan, so you can understand RD-162 rather than just read about it. In short: RD-162 is a second-generation nonsteroidal antiandrogen (NSAA) which was developed for the treatment of prostate cancer but was never marketed. It acts as a potent and selective silent antagonist of the androgen receptor (AR).

RD-162 — main illustration
RD-162 — illustration

Key takeaways

  • RD-162 belongs to chemistry; place it in that map before memorising details.
  • Learn the definition first, then one example that makes the definition concrete.
  • Connect RD-162 to a quantity you can measure, compute or draw — that is where exam questions come from.
  • Reproduce the core statement of RD-162 from memory before moving on to harder problems.

Reference excerpt

RD-162 is a second-generation nonsteroidal antiandrogen (NSAA) which was developed for the treatment of prostate cancer but was never marketed. It acts as a potent and selective silent antagonist of the androgen receptor (AR). The drug is a diarylthiohydantoin derivative. It is closely related to enzalutamide and apalutamide. Both RD-162 and enzalutamide show 5- to 8-fold higher affinity for the AR than the first-generation NSAA bicalutamide, and only 2- to 3-fold lower affinity than dihydrotestosterone (DHT), the major endogenous ligand of the receptor in the prostate gland. RD-162 and enzalutamide were developed together and were derived from the nonsteroidal androgen RU-59063, which itself was derived from the first-generation NSAA nilutamide. RD-162 and enzalutamide were selected as the lead compounds from a group of over 200 compounds that were synthesized and assayed for antiandrogenic activity. Enzalutamide was ultimately selected from the two for further clinical development and was eventually marketed. RD-162 is also very closely related to apalutamide, with the two compounds differing only by the replacement of a single atom (a carbon atom in one of the phenyl rings of RD-162 swapped with a nitrogen atom in apalutamide). Apalutamide was approved for the treatment of prostate cancer in 2018.

References

Illustrations

RD-162 illustration

Worked examples

Example 1 — a first encounter with RD-162

Start with the simplest possible case. Write down what RD-162 claims or describes in one sentence, then invent the smallest concrete situation in which that sentence is true. In chemistry, the smallest case is usually a single object, a single equation or a single measurement. Check that every symbol or term in your sentence has a meaning in that case.

Example 2 — changing one variable

Take the situation from Example 1 and change exactly one quantity: double it, halve it, or set it to zero. Predict what should happen to RD-162 before you calculate. Comparing your prediction with the result is the fastest way to find out whether you understand the idea or only the words.

Example 3 — an exam-style question

Typical questions about RD-162 ask you to (a) state it precisely, (b) apply it to given data, and (c) explain a limitation. Practise writing all three answers in under five minutes; the third part is what separates a full-mark answer from an average one.

Applications of RD-162

In research
RD-162 appears in chemistry research whenever the underlying quantities have to be modelled precisely. Papers usually cite it as a starting assumption and then explore where it breaks down.
In technology and industry
Engineering practice reuses RD-162 in design rules, simulations and safety margins. Knowing the idea lets you read a specification sheet and understand why the numbers look the way they do.
In the classroom
RD-162 is common in secondary-school and first-year university syllabi. It links to neighbouring topics 2-(Trifluoromethyl)benzonitriles, Abandoned drugs, Benzamides, so understanding it makes those chapters shorter.
In everyday life
Look for RD-162 outside the textbook — in sport, cooking, traffic, electronics or the sky above you. An example you found yourself is remembered far longer than one you were given.
Ask Teacher Smith questions about this articleOpens your AI tutor with a question about “RD-162” →

Affiliate

Preply — study more efficiently by working with a personal tutor. 50% off.

How to study RD-162 in 20 minutes

  1. Read the reference excerpt below once, without taking notes.
  2. Close the page and write down what RD-162 means in your own words.
  3. Compare your version with the excerpt and mark what you missed.
  4. Work through the three examples above with pen and paper.
  5. Explain RD-162 out loud to somebody else — or to Teacher Smith in the lgStudy chat.

Frequently asked questions

What is RD-162 in simple terms?

RD-162 is a second-generation nonsteroidal antiandrogen (NSAA) which was developed for the treatment of prostate cancer but was never marketed. It acts as a potent and selective silent antagonist of the androgen receptor (AR).

Why does RD-162 matter?

Because it connects several chemistry ideas at once: it gives you a definition you can apply, a quantity you can calculate, and a way to check whether a result is plausible.

How should I study RD-162?

Read the excerpt, restate it from memory, then work through the examples and applications listed on this page. The five-step study plan above takes about twenty minutes.

What does this page cover?

It gives you a compact reference excerpt plus original lgStudy explanations, examples, applications and study material on RD-162.

Tags

  • 2-(Trifluoromethyl)benzonitriles
  • Abandoned drugs
  • Benzamides
  • Fluorobenzene derivatives
  • Genito-urinary system drug stubs
  • Hormonal antineoplastic drugs
  • Nonsteroidal antiandrogens
  • Spiro compounds
  • Thiohydantoins

Keep exploring